<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lim JME</submitter><funding>Ministry of Health -Singapore</funding><funding>National Medical Research Council</funding><pagination>100793</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9534788</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>3(11)</volume><pubmed_abstract>Unlike mRNA vaccines based only on the spike protein, inactivated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines should induce a diversified T cell response recognizing distinct structural proteins. Here, we perform a comparative analysis of SARS-CoV-2-specific T cells in healthy individuals following vaccination with inactivated SARS-CoV-2 or mRNA vaccines. Relative to spike mRNA vaccination, inactivated vaccines elicit a lower magnitude of spike-specific T cells, but the combination of membrane, nucleoprotein, and spike-specific T cell response is quantitatively comparable with the sole spike T cell response induced by mRNA vaccine, and they efficiently tolerate the mutations characterizing the Omicron lineage. However, this multi-protein-specific T cell response i</pubmed_abstract><journal>Cell reports. Medicine</journal><pubmed_title>A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.</pubmed_title><pmcid>PMC9534788</pmcid><funding_grant_id>COVID19RF3-0060</funding_grant_id><funding_grant_id>COVID19RF-008</funding_grant_id><funding_grant_id>COVID19RF-001</funding_grant_id><pubmed_authors>Lye DC</pubmed_authors><pubmed_authors>Chia A</pubmed_authors><pubmed_authors>Hang SK</pubmed_authors><pubmed_authors>Tan N</pubmed_authors><pubmed_authors>Chng E</pubmed_authors><pubmed_authors>Lim JME</pubmed_authors><pubmed_authors>Lim PL</pubmed_authors><pubmed_authors>Le Bert N</pubmed_authors><pubmed_authors>Young BE</pubmed_authors><pubmed_authors>Lee ES</pubmed_authors><pubmed_authors>Tan AT</pubmed_authors><pubmed_authors>Bertoletti A</pubmed_authors><pubmed_authors>Hariharaputran S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines.</name><description>Unlike mRNA vaccines based only on the spike protein, inactivated severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccines should induce a diversified T cell response recognizing distinct structural proteins. Here, we perform a comparative analysis of SARS-CoV-2-specific T cells in healthy individuals following vaccination with inactivated SARS-CoV-2 or mRNA vaccines. Relative to spike mRNA vaccination, inactivated vaccines elicit a lower magnitude of spike-specific T cells, but the combination of membrane, nucleoprotein, and spike-specific T cell response is quantitatively comparable with the sole spike T cell response induced by mRNA vaccine, and they efficiently tolerate the mutations characterizing the Omicron lineage. However, this multi-protein-specific T cell response i</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-05-28T01:12:40.191Z</modification><creation>2024-10-18T22:32:10.972Z</creation></dates><accession>S-EPMC9534788</accession><cross_references><pubmed>36257326</pubmed><doi>10.1016/j.xcrm.2022.100793</doi></cross_references></HashMap>